Related references
Note: Only part of the references are listed.Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics
Hamad Alshetaiwi et al.
SCIENCE IMMUNOLOGY (2020)
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce
Harriet M. Kluger et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
Kurt A. Schalper et al.
NATURE MEDICINE (2020)
Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs
Betul Gokyavuz et al.
SCIENTIFIC REPORTS (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
Caroline Robert et al.
LANCET ONCOLOGY (2019)
CD45RA+CCR7- CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab
Andre Kunert et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
David J. Pinato et al.
JAMA ONCOLOGY (2019)
Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients
Brandilyn A. Peters et al.
GENOME MEDICINE (2019)
Improved metagenomic analysis with Kraken 2
Derrick E. Wood et al.
GENOME BIOLOGY (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Small Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary Lipids
Kristina Martinez-Guryn et al.
CELL HOST & MICROBE (2018)
Anti-PD-1 antibody treatment for melanoma
Antoni Ribas et al.
LANCET ONCOLOGY (2018)
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy
Carsten Krieg et al.
NATURE MEDICINE (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
Suppression of Tcf1 by Inflammatory Cytokines Facilitates Effector CD8 T Cell Differentiation
Maxime Danilo et al.
CELL REPORTS (2018)
Proliferation of PD-1+CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients
Alice O. Kamphorst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
Arthur E. Frankel et al.
NEOPLASIA (2017)
Hippurate as a metabolomic marker of gut microbiome diversity: Modulation by diet and relationship to metabolic syndrome
Tess Pallister et al.
SCIENTIFIC REPORTS (2017)
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients
M. F. Sanmamed et al.
ANNALS OF ONCOLOGY (2017)
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Zuguang Gu et al.
BIOINFORMATICS (2016)
Unexpected links reflect the noise in networks
Anatoly Yambartsev et al.
BIOLOGY DIRECT (2016)
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2016)
Reversing T-cell Dysfunction and Exhaustion in Cancer
Hassane M. Zarour
CLINICAL CANCER RESEARCH (2016)
Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and Pathogens
Melody Y. Zeng et al.
IMMUNITY (2016)
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
Antoni Ribas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health
Pamela Vernocchi et al.
FRONTIERS IN MICROBIOLOGY (2016)
MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph
Dinghua Li et al.
BIOINFORMATICS (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Microbiota Modulation of Myeloid Cells in Cancer Therapy
Romina S. Goldszmid et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma A Pooled Analysis of 4 Clinical Trials
James Larkin et al.
JAMA ONCOLOGY (2015)
The role of the microbiota in inflammation, carcinogenesis, and cancer therapy
Amiran Dzutsev et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Prokka: rapid prokaryotic genome annotation
Torsten Seemann
BIOINFORMATICS (2014)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
Clinical response of advanced cancer patients to cellular immunotherapy and intensity-modulated radiation therapy
Kenichiro Hasumi et al.
ONCOIMMUNOLOGY (2013)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
IL-18 Induces PD-1-Dependent Immunosuppression in Cancer
Magali Terme et al.
CANCER RESEARCH (2011)
Metagenomic biomarker discovery and explanation
Nicola Segata et al.
GENOME BIOLOGY (2011)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo
Sophie Guia et al.
BLOOD (2008)
An automated method for finding molecular complexes in large protein interaction networks
GD Bader et al.
BMC BIOINFORMATICS (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells
T Ohkawa et al.
IMMUNOLOGY (2001)
Cutting edge:: Cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression
MJ Pittet et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
